Drug sales bring huge profits, and scrutiny, to cancer doctors: insurers and experts see high costs and conflicts.

The New York times

Volumn , Issue , 2003, Pages

  Abelson, Reed ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CONFLICT OF INTEREST; DRUG COST; ECONOMICS; FEE; HEALTH CARE AND PUBLIC HEALTH; HUMAN; NEOPLASM; ONCOLOGY; PHYSICIAN; POPULAR APPROACH/SOURCE;

HEALTH CARE AND PUBLIC HEALTH; POPULAR APPROACH/SOURCE;

ANTINEOPLASTIC AGENTS; CONFLICT OF INTEREST; DRUG COSTS; FEES, PHARMACEUTICAL; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; PHYSICIANS;

EID: 0037673011     PISSN: 03624331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)